On June 1, 2009, Sunesis Pharmaceuticals, Inc. announced the results of new data from three ongoing clinical trials involving Sunesis' lead drug candidate, voreloxin, which were presented at the American Society of Clinical Oncology 2009 Annual Meeting in Orlando, Florida. A copy of the press release issued by Sunesis containing this announcement is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

(d) Exhibits

Exhibit
Number    Description
 99.1     Press release, dated June 1, 2009, entitled "Sunesis Pharmaceuticals
          Presents Voreloxin Clinical Data at the American Society of Clinical
          Oncology 2009 Annual Meeting."